The Experts below are selected from a list of 246 Experts worldwide ranked by ideXlab platform
Raffaella Bertolotti - One of the best experts on this subject based on the ideXlab platform.
-
benefits of e cigarettes in smoking reduction and in pulmonary health among chronic smokers undergoing a lung cancer screening program at 6 months
Addictive Behaviors, 2020Co-Authors: Claudio Lucchiari, Marianna Masiero, Ketti Mazzocco, Giulia Veronesi, Patrick Maisonneuve, C Jemos, Emanuela Omodeo Sale, Stefania Spina, Raffaella BertolottiAbstract:Abstract Introduction Electronic cigarettes (e-cigarettes) might be a valid and safe device to support smoking cessation. However, the available evidence is divergent. The aim of the present work was to assess the effects of an e-cigarette program on pulmonary health (cough, breath shortness, Catarrh) and to evaluate the effectiveness of e-cigarettes in reducing tobacco consumption. Methods The study is a double-blind randomized controlled trial. Two hundred and ten smokers were randomized into three groups: nicotine e-cigarette (8 mg/mL nicotine concentration), nicotine-free e-cigarettes (placebo), and control with 1:1:1 ratio. All participants received a 3 months cessation program that included a cognitive-behavioral intervention aimed at supporting people in changing their behavior and improving motivation to quit. Results Pulmonary health, assessed with self-reported measures, clinical evaluations and the Leicester Cough Questionnaire, improved in participants who stopped smoking compared to their own baseline. No differences in pulmonary health were found between groups. Statistical tests showed a significant effect of Group (F (2, 118) = 4.005, p Conclusions After 6 months about 20% of the entire sample stopped smoking. Participants who used e-cigarettes with nicotine smoked fewer tobacco cigarettes than any other group after 6 months (p
-
Benefits of e-cigarettes in smoking reduction and in pulmonary health among chronic smokers undergoing a lung cancer screening program at 6 months
'Elsevier BV', 2020Co-Authors: Claudio Lucchiari, Marianna Masiero, Ketti Mazzocco, Giulia Veronesi, Patrick Maisonneuve, C Jemos, Stefania Spina, Raffaella Bertolotti, Omodeo E. Salè, G. PravettoniAbstract:Introduction: Electronic cigarettes (e-cigarettes) might be a valid and safe device to support smoking cessation. However, the available evidence is divergent. The aim of the present work was to assess the effects of an e-cigarette program on pulmonary health (cough, breath shortness, Catarrh) and to evaluate the effectiveness of e-cigarettes in reducing tobacco consumption. Methods: The study is a double-blind randomized controlled trial. Two hundred and ten smokers were randomized into three groups: nicotine e-cigarette (8 mg/mL nicotine concentration), nicotine-free e-cigarettes (placebo), and control with 1:1:1 ratio. All participants received a 3 months cessation program that included a cognitive-behavioral intervention aimed at supporting people in changing their behavior and improving motivation to quit. Results: Pulmonary health, assessed with self-reported measures, clinical evaluations and the Leicester Cough Questionnaire, improved in participants who stopped smoking compared to their own baseline. No differences in pulmonary health were found between groups. Statistical tests showed a significant effect of Group (F (2, 118) = 4.005, p <.020) on daily cigarette consumption: after 6 months participants in the nicotine e-cigarette group smoked fewer cigarettes than any other group. Moreover, participants in this group showed the lowest level of exhaled carbon monoxide (CO) (M = 12.012, S.D. = 8.130), and the lowest level of dependence (M = 3.12, S.D. = 2.29) compared to the nicotine-free e-cigarette and control conditions. Conclusions: After 6 months about 20% of the entire sample stopped smoking. Participants who used e-cigarettes with nicotine smoked fewer tobacco cigarettes than any other group after 6 months (p <.020). Our data add to the efficacy and safety of e-cigarettes in helping smokers reducing tobacco consumption and improving pulmonary health status
Marianna Masiero - One of the best experts on this subject based on the ideXlab platform.
-
benefits of e cigarettes in smoking reduction and in pulmonary health among chronic smokers undergoing a lung cancer screening program at 6 months
Addictive Behaviors, 2020Co-Authors: Claudio Lucchiari, Marianna Masiero, Ketti Mazzocco, Giulia Veronesi, Patrick Maisonneuve, C Jemos, Emanuela Omodeo Sale, Stefania Spina, Raffaella BertolottiAbstract:Abstract Introduction Electronic cigarettes (e-cigarettes) might be a valid and safe device to support smoking cessation. However, the available evidence is divergent. The aim of the present work was to assess the effects of an e-cigarette program on pulmonary health (cough, breath shortness, Catarrh) and to evaluate the effectiveness of e-cigarettes in reducing tobacco consumption. Methods The study is a double-blind randomized controlled trial. Two hundred and ten smokers were randomized into three groups: nicotine e-cigarette (8 mg/mL nicotine concentration), nicotine-free e-cigarettes (placebo), and control with 1:1:1 ratio. All participants received a 3 months cessation program that included a cognitive-behavioral intervention aimed at supporting people in changing their behavior and improving motivation to quit. Results Pulmonary health, assessed with self-reported measures, clinical evaluations and the Leicester Cough Questionnaire, improved in participants who stopped smoking compared to their own baseline. No differences in pulmonary health were found between groups. Statistical tests showed a significant effect of Group (F (2, 118) = 4.005, p Conclusions After 6 months about 20% of the entire sample stopped smoking. Participants who used e-cigarettes with nicotine smoked fewer tobacco cigarettes than any other group after 6 months (p
-
Benefits of e-cigarettes in smoking reduction and in pulmonary health among chronic smokers undergoing a lung cancer screening program at 6 months
'Elsevier BV', 2020Co-Authors: Claudio Lucchiari, Marianna Masiero, Ketti Mazzocco, Giulia Veronesi, Patrick Maisonneuve, C Jemos, Stefania Spina, Raffaella Bertolotti, Omodeo E. Salè, G. PravettoniAbstract:Introduction: Electronic cigarettes (e-cigarettes) might be a valid and safe device to support smoking cessation. However, the available evidence is divergent. The aim of the present work was to assess the effects of an e-cigarette program on pulmonary health (cough, breath shortness, Catarrh) and to evaluate the effectiveness of e-cigarettes in reducing tobacco consumption. Methods: The study is a double-blind randomized controlled trial. Two hundred and ten smokers were randomized into three groups: nicotine e-cigarette (8 mg/mL nicotine concentration), nicotine-free e-cigarettes (placebo), and control with 1:1:1 ratio. All participants received a 3 months cessation program that included a cognitive-behavioral intervention aimed at supporting people in changing their behavior and improving motivation to quit. Results: Pulmonary health, assessed with self-reported measures, clinical evaluations and the Leicester Cough Questionnaire, improved in participants who stopped smoking compared to their own baseline. No differences in pulmonary health were found between groups. Statistical tests showed a significant effect of Group (F (2, 118) = 4.005, p <.020) on daily cigarette consumption: after 6 months participants in the nicotine e-cigarette group smoked fewer cigarettes than any other group. Moreover, participants in this group showed the lowest level of exhaled carbon monoxide (CO) (M = 12.012, S.D. = 8.130), and the lowest level of dependence (M = 3.12, S.D. = 2.29) compared to the nicotine-free e-cigarette and control conditions. Conclusions: After 6 months about 20% of the entire sample stopped smoking. Participants who used e-cigarettes with nicotine smoked fewer tobacco cigarettes than any other group after 6 months (p <.020). Our data add to the efficacy and safety of e-cigarettes in helping smokers reducing tobacco consumption and improving pulmonary health status
Claudio Lucchiari - One of the best experts on this subject based on the ideXlab platform.
-
benefits of e cigarettes in smoking reduction and in pulmonary health among chronic smokers undergoing a lung cancer screening program at 6 months
Addictive Behaviors, 2020Co-Authors: Claudio Lucchiari, Marianna Masiero, Ketti Mazzocco, Giulia Veronesi, Patrick Maisonneuve, C Jemos, Emanuela Omodeo Sale, Stefania Spina, Raffaella BertolottiAbstract:Abstract Introduction Electronic cigarettes (e-cigarettes) might be a valid and safe device to support smoking cessation. However, the available evidence is divergent. The aim of the present work was to assess the effects of an e-cigarette program on pulmonary health (cough, breath shortness, Catarrh) and to evaluate the effectiveness of e-cigarettes in reducing tobacco consumption. Methods The study is a double-blind randomized controlled trial. Two hundred and ten smokers were randomized into three groups: nicotine e-cigarette (8 mg/mL nicotine concentration), nicotine-free e-cigarettes (placebo), and control with 1:1:1 ratio. All participants received a 3 months cessation program that included a cognitive-behavioral intervention aimed at supporting people in changing their behavior and improving motivation to quit. Results Pulmonary health, assessed with self-reported measures, clinical evaluations and the Leicester Cough Questionnaire, improved in participants who stopped smoking compared to their own baseline. No differences in pulmonary health were found between groups. Statistical tests showed a significant effect of Group (F (2, 118) = 4.005, p Conclusions After 6 months about 20% of the entire sample stopped smoking. Participants who used e-cigarettes with nicotine smoked fewer tobacco cigarettes than any other group after 6 months (p
-
Benefits of e-cigarettes in smoking reduction and in pulmonary health among chronic smokers undergoing a lung cancer screening program at 6 months
'Elsevier BV', 2020Co-Authors: Claudio Lucchiari, Marianna Masiero, Ketti Mazzocco, Giulia Veronesi, Patrick Maisonneuve, C Jemos, Stefania Spina, Raffaella Bertolotti, Omodeo E. Salè, G. PravettoniAbstract:Introduction: Electronic cigarettes (e-cigarettes) might be a valid and safe device to support smoking cessation. However, the available evidence is divergent. The aim of the present work was to assess the effects of an e-cigarette program on pulmonary health (cough, breath shortness, Catarrh) and to evaluate the effectiveness of e-cigarettes in reducing tobacco consumption. Methods: The study is a double-blind randomized controlled trial. Two hundred and ten smokers were randomized into three groups: nicotine e-cigarette (8 mg/mL nicotine concentration), nicotine-free e-cigarettes (placebo), and control with 1:1:1 ratio. All participants received a 3 months cessation program that included a cognitive-behavioral intervention aimed at supporting people in changing their behavior and improving motivation to quit. Results: Pulmonary health, assessed with self-reported measures, clinical evaluations and the Leicester Cough Questionnaire, improved in participants who stopped smoking compared to their own baseline. No differences in pulmonary health were found between groups. Statistical tests showed a significant effect of Group (F (2, 118) = 4.005, p <.020) on daily cigarette consumption: after 6 months participants in the nicotine e-cigarette group smoked fewer cigarettes than any other group. Moreover, participants in this group showed the lowest level of exhaled carbon monoxide (CO) (M = 12.012, S.D. = 8.130), and the lowest level of dependence (M = 3.12, S.D. = 2.29) compared to the nicotine-free e-cigarette and control conditions. Conclusions: After 6 months about 20% of the entire sample stopped smoking. Participants who used e-cigarettes with nicotine smoked fewer tobacco cigarettes than any other group after 6 months (p <.020). Our data add to the efficacy and safety of e-cigarettes in helping smokers reducing tobacco consumption and improving pulmonary health status
Janet A Wilson - One of the best experts on this subject based on the ideXlab platform.
-
the conversion from sensation to symptom the case of Catarrh a qualitative study
Chronic Illness, 2012Co-Authors: Russell Cathcart, Janet A Wilson, Carl MayAbstract:Objective: There is significant variation in symptom tolerance before seeking healthcare advice and it has recently been postulated that there may be a similar variation in the degree to which individuals tolerate deviations in physiological body sensations before considering them symptoms. This study looked to explore this transition from sensation to symptom more closely using the clinical entity of chronic Catarrh – a frequently presenting problem which represents a putative alteration of a physiological process.Design: Qualitative study using semi-structured interviews.Participants: 19 adult patients presenting with chronic Catarrh, persistent throat clearing or post-nasal drip.Setting: Secondary care institute in North of England.Results: Subjects’ accounts revealed three changes in perception of nasopharyngeal mucus that triggered the transition from sensation to symptom: an apparent change in viscosity, quantity, or constancy. Such changes were invariably deemed to have a consequence (threat to wel...
-
Catarrh the patient experience
Rhinology, 2011Co-Authors: Russell Cathcart, Janet A WilsonAbstract:Background No study to date has looked at the symptoms of chronic Catarrh as defined by the patients themselves. We looked to explore the Catarrh experience through the eyes of patients using a qualitative approach. Methodology/principal Forty-eight patients referred to Secondary Care with chronic Catarrh, postnasal drip or persistent throat clearing completed an open-ended questionnaire from which a comprehensive symptom list was generated. Nineteen of these patients undertook semi-structured interviews to explore symptomatic themes relating to their Catarrh using grounded theory analysis. Results A standardised list of 38 Catarrh-related symptoms was generated covering a wide topography. A common theme amongst interviewees was the frustration of being unable to expectorate mucus rather than expelling too much. Conclusions Difficulties exist in establishing whether the extensive list of symptoms associated with Catarrh is a result of differing experiences for patients or simply differing lexicon describing the same experience. Many of these symptoms are not included in the most commonly used nose/throat symptom instruments. Furthermore a distinction should be made between patients with true rhinitis who expel mucus and those who present with apparent postnasal drip or throat clearing but who cannot expectorate, whose management ought be focused more on symptom-coping strategies rather than medication or investigation.
-
should chronic Catarrh patients seen in primary care be referred for further investigations
International Journal of Clinical Practice, 2011Co-Authors: Russell Cathcart, Janet A WilsonAbstract:Summary Background: Chronic Catarrh is commonly encountered in primary care, but often presents a quandary to the clinician because the history of postnasal or pharyngeal mucus build-up is frequently at odds with the absence of physical findings. As with certain other medically mysterious syndromes, the value of often costly investigation remains unclear in both the primary and the secondary care settings. Indeed, investigation may reassure the physician more than the patient (1) and could even prove counter-productive through reinforcement of the patient’s belief about the presence of significant pathology (2). Aim: To establish the benefit of referral of chronic Catarrh patients for specialist investigation. Design: A cross-sectional survey. Setting: A total of 138 patients referred to secondary care with chronic Catarrh, postnasal drip or throat clearing in the north of England. Methods: Subjects completed three disease-specific symptom-scoring questionnaires (RSI, SNOT-20 and GETS). Investigations performed were saccharin clearance time, nasendoscopy, skinprick allergy testing and CT of sinuses. Results were compared with published values. Results: Catarrh patients scored highly on all three symptom questionnaires. Nasendoscopy was normal in 70% of patients, with the remainder demonstrating mostly simple mucus (20%), lymphoid tissue (6%) or mucopus (2%). Only 6 of the 136 patients tested had a prolonged saccharin clearance time greater than 30 min. The mean score of the 63 sinus CT scans obtained was 2.6 (normal range = 0–5). Of patients undergoing skinprick testing (n = 45), 30% reacted to one or more inhaled allergen. No rhinological investigation yielded results above that expected in the general population. Conclusion: Chronic Catarrh appears to be related more to pharyngeal symptom awareness than to pathological postnasal drip or mucus over-production. Rhinological investigations have a limited role in the management of chronic Catarrh patients. The principal outcome of ENT referral is likely to be reassurance and direction towards patient self-help information.
-
health beliefs and expectations amongst chronic Catarrh sufferers
Clinical Otolaryngology, 2008Co-Authors: Russell Cathcart, Janet A Wilson, Carl MayAbstract:Background. The mere presence of Catarrh does not, in itself, compel medical help-seeking: many experience Catarrh and never seek help for it, while others do so after months or even years. We aimed to explore the triggers of help-seeking in chronic Catarrh patients, along with their general health beliefs and the expectations that they hold about the health services that they approach. Method. A qualitative study using digitally taped semi-structured interviews of 19 chronic Catarrh patients, with full ethical approval. Narrative analysis was performed on the transcribed interviews, using a constant comparative technique approach to the generation of grounded theory, through a process of manual coding and categorisation. Emergent categories were checked for goodness of fit. Results. Catarrh came to prominence for sufferers through a global shift in body concerns or a relative shift in symptom heirarchy subsequent to a lack of explanation or treatments. Catarrh sufferers had narrow, family-based lay networks which they found to be frequently dismissive. Temporalisation and worsening of symptoms were the predominant triggers for seeking help. Sufferers attended GPs for a ‘quick-fix’ and hospitals for ‘investigations’. Short-term sufferers sought a cure for their symptoms whilst long-term sufferers accepted reassurance. Conclusions. Explanantion and closure should be primary aims in managing Catarrh patients. Although resolution of symptoms is the pervading hope of chronic Catarrh sufferers, a significant majority of interviewees, particularly long-term sufferers, admitted that they could live with their symptoms so long as they could be given reassurance that pathology was absent and no treatment option overlooked.
Russell Cathcart - One of the best experts on this subject based on the ideXlab platform.
-
the conversion from sensation to symptom the case of Catarrh a qualitative study
Chronic Illness, 2012Co-Authors: Russell Cathcart, Janet A Wilson, Carl MayAbstract:Objective: There is significant variation in symptom tolerance before seeking healthcare advice and it has recently been postulated that there may be a similar variation in the degree to which individuals tolerate deviations in physiological body sensations before considering them symptoms. This study looked to explore this transition from sensation to symptom more closely using the clinical entity of chronic Catarrh – a frequently presenting problem which represents a putative alteration of a physiological process.Design: Qualitative study using semi-structured interviews.Participants: 19 adult patients presenting with chronic Catarrh, persistent throat clearing or post-nasal drip.Setting: Secondary care institute in North of England.Results: Subjects’ accounts revealed three changes in perception of nasopharyngeal mucus that triggered the transition from sensation to symptom: an apparent change in viscosity, quantity, or constancy. Such changes were invariably deemed to have a consequence (threat to wel...
-
Catarrh the patient experience
Rhinology, 2011Co-Authors: Russell Cathcart, Janet A WilsonAbstract:Background No study to date has looked at the symptoms of chronic Catarrh as defined by the patients themselves. We looked to explore the Catarrh experience through the eyes of patients using a qualitative approach. Methodology/principal Forty-eight patients referred to Secondary Care with chronic Catarrh, postnasal drip or persistent throat clearing completed an open-ended questionnaire from which a comprehensive symptom list was generated. Nineteen of these patients undertook semi-structured interviews to explore symptomatic themes relating to their Catarrh using grounded theory analysis. Results A standardised list of 38 Catarrh-related symptoms was generated covering a wide topography. A common theme amongst interviewees was the frustration of being unable to expectorate mucus rather than expelling too much. Conclusions Difficulties exist in establishing whether the extensive list of symptoms associated with Catarrh is a result of differing experiences for patients or simply differing lexicon describing the same experience. Many of these symptoms are not included in the most commonly used nose/throat symptom instruments. Furthermore a distinction should be made between patients with true rhinitis who expel mucus and those who present with apparent postnasal drip or throat clearing but who cannot expectorate, whose management ought be focused more on symptom-coping strategies rather than medication or investigation.
-
should chronic Catarrh patients seen in primary care be referred for further investigations
International Journal of Clinical Practice, 2011Co-Authors: Russell Cathcart, Janet A WilsonAbstract:Summary Background: Chronic Catarrh is commonly encountered in primary care, but often presents a quandary to the clinician because the history of postnasal or pharyngeal mucus build-up is frequently at odds with the absence of physical findings. As with certain other medically mysterious syndromes, the value of often costly investigation remains unclear in both the primary and the secondary care settings. Indeed, investigation may reassure the physician more than the patient (1) and could even prove counter-productive through reinforcement of the patient’s belief about the presence of significant pathology (2). Aim: To establish the benefit of referral of chronic Catarrh patients for specialist investigation. Design: A cross-sectional survey. Setting: A total of 138 patients referred to secondary care with chronic Catarrh, postnasal drip or throat clearing in the north of England. Methods: Subjects completed three disease-specific symptom-scoring questionnaires (RSI, SNOT-20 and GETS). Investigations performed were saccharin clearance time, nasendoscopy, skinprick allergy testing and CT of sinuses. Results were compared with published values. Results: Catarrh patients scored highly on all three symptom questionnaires. Nasendoscopy was normal in 70% of patients, with the remainder demonstrating mostly simple mucus (20%), lymphoid tissue (6%) or mucopus (2%). Only 6 of the 136 patients tested had a prolonged saccharin clearance time greater than 30 min. The mean score of the 63 sinus CT scans obtained was 2.6 (normal range = 0–5). Of patients undergoing skinprick testing (n = 45), 30% reacted to one or more inhaled allergen. No rhinological investigation yielded results above that expected in the general population. Conclusion: Chronic Catarrh appears to be related more to pharyngeal symptom awareness than to pathological postnasal drip or mucus over-production. Rhinological investigations have a limited role in the management of chronic Catarrh patients. The principal outcome of ENT referral is likely to be reassurance and direction towards patient self-help information.
-
health beliefs and expectations amongst chronic Catarrh sufferers
Clinical Otolaryngology, 2008Co-Authors: Russell Cathcart, Janet A Wilson, Carl MayAbstract:Background. The mere presence of Catarrh does not, in itself, compel medical help-seeking: many experience Catarrh and never seek help for it, while others do so after months or even years. We aimed to explore the triggers of help-seeking in chronic Catarrh patients, along with their general health beliefs and the expectations that they hold about the health services that they approach. Method. A qualitative study using digitally taped semi-structured interviews of 19 chronic Catarrh patients, with full ethical approval. Narrative analysis was performed on the transcribed interviews, using a constant comparative technique approach to the generation of grounded theory, through a process of manual coding and categorisation. Emergent categories were checked for goodness of fit. Results. Catarrh came to prominence for sufferers through a global shift in body concerns or a relative shift in symptom heirarchy subsequent to a lack of explanation or treatments. Catarrh sufferers had narrow, family-based lay networks which they found to be frequently dismissive. Temporalisation and worsening of symptoms were the predominant triggers for seeking help. Sufferers attended GPs for a ‘quick-fix’ and hospitals for ‘investigations’. Short-term sufferers sought a cure for their symptoms whilst long-term sufferers accepted reassurance. Conclusions. Explanantion and closure should be primary aims in managing Catarrh patients. Although resolution of symptoms is the pervading hope of chronic Catarrh sufferers, a significant majority of interviewees, particularly long-term sufferers, admitted that they could live with their symptoms so long as they could be given reassurance that pathology was absent and no treatment option overlooked.